Table 3C. Relationships between GNRI and clinicopathological features in patients with ESCC stage III.
| Characteristics | Total patients | GNRI | ||
|---|---|---|---|---|
| < 97.1 (n = 41) | ≥ 97.1 (n = 36) | p value | ||
| Age (years) | 64 (48–84) | 67 (49–84) | 0.5810 | |
| Sex | 0.0534 | |||
| Male | 71 | 40 | 31 | |
| Female | 6 | 1 | 5 | |
| BMI | 18.5 (15.2–26.3) | 22.3 (16.9–31.8) | < 0.0001 | |
| WBC | 6700 (2560–12240) | 5560 (3280–17140) | 0.3025 | |
| Neutrophil | 4270 (849–9420) | 3408 (2268–15169) | 0.3171 | |
| Lymphocyte | 1480 (179–3390) | 1605 (380–3340) | 0.7170 | |
| Platelet | 25.5 (8.7–49.5) | 22.5 (14.5 – 38.0) | 0.1269 | |
| Location of tumor | 0.7522 | |||
| Ce | 7 | 5 | 2 | |
| Ut | 3 | 1 | 2 | |
| Mt | 31 | 15 | 16 | |
| Lt | 30 | 17 | 13 | |
| Ae | 6 | 3 | 3 | |
| Tumor size (mm) | 5.5 (2.0–70.0) | 4.7 (1.3–32.0) | 0.0473 | |
| Depth of tumor | 0.0071 | |||
| T1a–1b | 3 | 0 | 3 | |
| 2 | 1 | 0 | 1 | |
| 3 | 54 | 26 | 28 | |
| 4a–4b | 19 | 15 | 4 | |
| Lymph node metastasis | 0.0076 | |||
| N0 | 8 | 7 | 1 | |
| N1 | 34 | 21 | 13 | |
| N2 | 20 | 5 | 15 | |
| N3 | 15 | 8 | 7 | |
| Operation time (min) | 665 (230–986) | 664 (196–1113) | 0.9756 | |
| Intraoperative blood loss (ml) | 660 (0–10000) | 280 (0–1650) | 0.0191 | |
| SCC antigen | 1.3 (0.4–20.8) | 1.1 (0.1–6.0) | 0.3091 | |
| Albumin | 3.6 (2.3–4.2) | 4.2 (3.3–4.8) | < 0.0001 | |
| CRP | 0.45 (0.01–6.02) | 0.18 (0.02–4.00) | 0.0019 | |